Verkerk K, van der Wel TJWT, Zeverijn LJ, Geurts BS, et al. Safety, Efficacy and Biomarker Analysis of Crizotinib in MET Mutated Non-Small Cell Lung Cancer - Results from the Drug Rediscovery Protocol. Clin Cancer Res 2024 Oct 1. doi: 10.1158/1078-0432.CCR-24-1925.
PMID: 39352721